FDA Approvals in Oncology: April-June 2025
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
Cancer Today's 2025 summer issue covers the expanded use of neoadjuvant immunotherapy, PSMA-targeted therapy for prostate cancer, and more.
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving...
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could...
Researchers are looking into urine tests that could detect cancers earlier, including lung, ovarian, pancreatic, colorectal, and more.
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
A poster at the AACR Annual Meeting 2024 examined a video that increased awareness of prostate cancer.
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...
Prostate cancer is the most common non-skin cancer in men, and is the second leading cause of cancer-related death among men in the United States. Although there...